# Cancer Prevention and Control Research Program

> **NIH NIH P30** · EMORY UNIVERSITY · 2024 · $55,733

## Abstract

PROJECT SUMMARY/ABSTRACT
CANCER PREVENTION AND CONTROL PROGRAM
The Cancer Prevention and Control (CPC) Program of Winship Cancer Institute of Emory University (Winship)
coordinates and promotes all cancer prevention and control-related research activities within the center. The
goal of CPC Program is to generate knowledge through innovative research and learning from the community,
that will transform cancer prevention and care and reduce the cancer burden in Winship’s catchment area, the
state of Georgia, and beyond. CPC has four scientific themes: (1) Cancer Epidemiology - to achieve high quality
surveillance of the cancer burden and identify risk factors such as biological, behavioral, social and policy factors,
and environmental exposures, to inform targeted interventions and strategies to reduce cancer risk in Georgia;
(2) Interventions - focus on HPV vaccination uptake, individual behavioral interventions to reduce tobacco use
and to prevent weight gain, and policy and systems-level changes with the ultimate goal of broad-scale
implementation of effective strategies; (3) Cancer Survivorship and Symptom Management - focus on treatment-
related early effects, including patient-reported outcomes, biobehavioral changes in the brain, childhood and
adolescent cancer survivors transition to primary care, and late effects such as cardiovascular disease, which
substantially affect the quality-of-life of cancer patients and survivors; and (4) Quality of Cancer Care - to conduct
population-based research that describes, interprets, and predicts the impact of health care interventions and
other factors on adherence to care, quality of cancer care, inequities in care, and outcomes. Under the leadership
of Timothy L. Lash, DSc, MPH (leader) and Mylin Torres, MD (co-leader), CPC includes 53 core members
representing 16 different departments within the School of Medicine, Nell Hodgson Woodruff School of Nursing,
and Rollins School of Public Health at Emory University. This diverse membership furnishes a rich research
training environment for the next generation of cancer researchers. CPC engages in ongoing interactions with
Community Outreach and Engagement (COE) to inform research on catchment area priorities and actively
engages in promoting biomedical scientific careers for under-represented groups. This highly collaborative group
of researchers published 1,074 cancer-relevant scientific articles during the current funding period. Of these, 275
(26%) were intra- and 290 (27%) were inter-programmatic collaborations and 779 (73%) represented a
collaboration with an external academic organization. 144 (13%) were published in journals with an impact
factor of ≥ 10. As of end of 2021, CPC members held $14.5 million in annual total cancer-relevant research
funding, of which $11.3 million is peer-reviewed (78%) and $8.6 million (59%) was awarded directly from NCI.
Funding from NCI increased from $4.4 million in 2016 to $8.6 million in 2021. Notable new funding...

## Key facts

- **NIH application ID:** 10848271
- **Project number:** 5P30CA138292-15
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Timothy L. Lash
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $55,733
- **Award type:** 5
- **Project period:** 2009-04-07 → 2028-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10848271

## Citation

> US National Institutes of Health, RePORTER application 10848271, Cancer Prevention and Control Research Program (5P30CA138292-15). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10848271. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*